Fedha

Hisa unazofuatilia
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK 429.40
+0.51%
(+2.20) Siku 1
14 Okt, 12:32:25 GMT +2  ·   SEK
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya SOBI...
Fungua
SEK 427.40
Juu
SEK 429.40
Chini
SEK 424.80
Mtaji wa soko
153.57B
Wastani wa kiasi cha mauzo
elfu 255.84
Kiasi cha mauzo ya hisa
elfu 57.88
Uwiano wa bei ya hisa na mapato kwa kila hisa
114.69
Juu kwa wiki 52
SEK 487.00
Chini kwa wiki 52
SEK 293.60
EPS
SEK 3.74
Hisa za wawekezaji
357.64M
Idadi ya wafanyakazi
elfu 2
Fungua
SEK 427.40
Juu
SEK 429.40
Chini
SEK 424.80
Mtaji wa soko
153.57B
Wastani wa kiasi cha mauzo
elfu 255.84
Kiasi cha mauzo ya hisa
elfu 57.88
Uwiano wa bei ya hisa na mapato kwa kila hisa
114.69
Juu kwa wiki 52
SEK 487.00
Chini kwa wiki 52
SEK 293.60
EPS
SEK 3.74
Hisa za wawekezaji
357.64M
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA. Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Kuhusu Swedish Orphan Biovitrum AB (publ)
Afisa Mkuu Mtendaji (CEO)Guido Oelkers
Wafanyakazielfu 2.12
Lilianzishwa1939
Makao makuu-
Sekta-
Tovutisobi.com
Ripoti za awaliThamani zote katika SEK
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika SEK
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
7.78B
7.82B
7.18B
7.84B
Gharama ya bidhaa zilizouzwa
1.56B
1.51B
1.70B
1.83B
Gharama ya mapato
1.56B
1.51B
1.70B
1.83B
Gharama za utafiti na maendeleo
754.00M
879.00M
948.00M
1.13B
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
2.63B
2.93B
2.62B
2.89B
Gharama ya uendeshaji
3.41B
3.75B
3.57B
4.03B
Jumla ya gharama za uendeshaji
4.97B
5.26B
5.27B
5.86B
Mapato ya uendeshaji
2.80B
2.56B
1.91B
1.98B
Mapato mengine yasiyo ya uendeshaji
1.00M
-25.00M
1.00M
1.00M
EBT ikijumuisha vipengee visivyo vya kawaida
-4.03B
2.17B
1.68B
1.41B
EBT bila kujumuisha vipengee visivyo vya kawaida
2.64B
2.32B
1.72B
1.77B
Gharama ya kodi ya mapato
-1.13B
310.00M
363.00M
315.00M
Kiwango cha kodi kinachotumika
28.12%
14.27%
21.59%
22.29%
Gharama nyingine za uendeshaji
26.00M
-57.00M
1.00M
8.00M
Mapato halisi
-2.89B
1.86B
1.32B
1.10B
Kiwango cha faida halisi
-37.22%
23.81%
18.35%
13.99%
Mapato kwa kila hisa
6.05
5.65
4.07
3.96
Mapato ya riba na uwekezaji
-
22.00M
-
-
Gharama ya riba
-168.00M
-156.00M
-173.00M
-204.00M
Jumla ya gharama halisi za riba
-168.00M
-134.00M
-173.00M
-204.00M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
3.71B
3.13B
2.69B
2.78B
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google